“Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective”, FE, vol. 20, no. 1, Jul. 2019, doi: 10.7175/fe.v20i1.1437.